Issued Patents All Time
Showing 26–43 of 43 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6448263 | Treatment of insulin resistance with growth hormone secretagogues | Charles Kwok-Fung Chiu, Lydia Pan, Bruce Lefker, Judith Treadway, Michael P. Zawistoski | 2002-09-10 |
| 6433171 | Dipeptide derivatives | David A. Griffith, Bruce Lefker | 2002-08-13 |
| 6432945 | Dipeptide derivatives | David A. Griffith, Bruce Lefker | 2002-08-13 |
| 6429313 | Dipeptide derivatives | David A. Griffith, Bruce Lefker | 2002-08-06 |
| 6407120 | Neuropeptide Y antagonists | Marlys Hammond, Richard F. Hank | 2002-06-18 |
| 6372743 | Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines | James Darrow, Stéphane De Lombaert, Charles A. Blum, Jennifer Tran, Mark Giangiordano +1 more | 2002-04-16 |
| 6358951 | Growth hormone secretagogues | — | 2002-03-19 |
| 6337332 | Neuropeptide Y receptor antagonists | — | 2002-01-08 |
| 6313140 | Method of treatment using certain growth-hormone secret agogues | Paul DaSilva-Jardine, Bruce Lefker, John Ragan | 2001-11-06 |
| 6306875 | Growth-hormone secretagogues | Paul DaSilva-Jardine, Bruce Lefker, John Ragan | 2001-10-23 |
| 6278000 | Growth-hormone secretagogues | Paul DaSilva-Jardine, Bruce Lefker, John Ragan | 2001-08-21 |
| 6251902 | Dipeptide derivatives as growth hormone secretagogues | David A. Griffith, Bruce Lefker | 2001-06-26 |
| 6248717 | Tartrate salt of a substituted dipeptide as growth hormone secretagogue | Paul DaSilva-Jardine, Bruce Lefker, Jerry A. Murry | 2001-06-19 |
| 6124264 | Heterocyclic compounds | Paul DaSilva-Jardine, Bruce Lefker, John Ragan | 2000-09-26 |
| 6110932 | Growth hormone secretagogues | Paul DaSilva-Jardine, Bruce Lefker, John Ragan | 2000-08-29 |
| 6107306 | Heterocyclic compounds | Paul DaSilva-Jardine, Bruce Lefker, John Ragan | 2000-08-22 |
| 5936089 | Dipeptides which promote release of growth hormone | Paul DaSilva-Jardine, Bruce Lefker, John Ragan | 1999-08-10 |
| 5789415 | Azacyclic-heterocyclic compounds as angiotension II receptor antagonists | Eric R. Larson, Banavara L. Mylari | 1998-08-04 |